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1 Introduction
We are living in an age of outsourcing (Grossman and Helpman 2005). The
ongoing process of outsourcing has even gone global by taking the form of offshore
outsourcing — the relocation of business functions to an offshore provider external to
the firm. Recently, offshore outsourcing is no longer limited to what firms perceive as
non-core functions such as customer call centers or billing/collections; firms are now
outsourcing key tasks such as research and development (R&D) to offshore providers
through contractual R&D.
There is considerable evidence of this new trend in a variety of industries. In the
pharmaceutical industry, the largest multinational pharmaceutical firms, including
Merck, Eli Lilly, and Johnson & Johnson, first moved manufacturing and clinical-
trial work to China and India. And now, driven by cost pressures and growth op-
portunities, they are partnering with firms there to do sophisticated drug research
and clinical testing (Wadhwa 2008a). Indian companies such as Ranbaxy, Advinus
Therapeutics, Nicholas Piramal and Jubilant have negotiated long-term deals with
western pharmaceutical companies to discover and develop new chemical entities. A
Chinese company, Hutchison MediPharma, has formed a similar partnership with Eli
Lilly (Wadhwa 2008b). There is also a fast expansion of offshore outsourcing of R&D
in the information technology (IT) industry. A lot of multinational IT firms, like
Dell, Motorola and Philips are buying not only cell phones but also complete designs
of some digital services from Asian developers. The R&D outsourcing market for
information technology in India is projected to grow to more than $9 billion by 2010
from $1.3 billion in 2003, according to a study conducted by a business consulting
firm Frost & Sullivan (Frost & Sullivan 2004). In the aerospace industry, Boeing Co.
is working with India’s HCL technologies to co-develop software for everything from
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navigation systems and landing gear to its upcoming 7E7 Dreamliner jet (Engardio
and Einhorn 2005).
At the macro level, data on licensing payments also show the boost of contrac-
tual R&D between multinational firms and local firms in developing countries. For
example, U.S. licensing payments to Chinese firms rose from $1 million in 1995 to
$13 million in 2000, reaching $115 million in 2007. U.S. licensing payments to Indian
firms rose from $2 million in 2000 to $98 million in 2007.1 China’s official balance
of payment statistics show that the licensing fee payments received by Chinese firms
have registered a substantial increase, from US$82 million in 2000 to US$343 million
in 2007. This highlights the fact that developing countries such as China and India
have been increasingly engaged in the vertical specialization of global R&D activities.
There are several reasons for the proliferation of international specialization in
R&D activities. 2 First, several developing countries, for example, India, China, and
Brazil, have succeeded in building up research and development capacity in recent
years, thereby reducing the technology gap between developed countries and devel-
oping countries. Second, research and development in some industries, for example,
the pharmaceutical industry, is highly complex and prohibitively expensive. With
intensifying globalization, multinational firms are under pressure to reduce the costs
involved in R&D. Factors like lower labor cost, time saving due to the time zone
difference between some developed countries and developing countries, higher patient
enrolment rates as well as the prevalence of a wide variety of diseases and a heteroge-
1The data is from the U.S. Department of Commerce, available at
http://www.bea.gov/international/intlserv.htm
2Ernst (2005) attributes internationalization of innovation to the following: (1) institutional
change through liberalization; (2) the impact of information and communication technology; (3)
market competition and organizational change; adjustments in corporate strategy and business
models.
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neous gene pool all contribute to the cost advantage in the drug research process.3 As
a result, the strategy of multinational firms is to specialize in a particular component
of the R&D chain by which cost reduction in R&D could be achieved.
The offshore outsourcing of R&D presents fresh opportunities for developing
countries in promoting their R&D activities, yet it creates new challenges to their
intellectual property right (IPR) policy. While multinational firms (MNEs) find it
profitable in the short term by engaging in offshore outsourcing of R&D, there are
growing concerns about the loss of core proprietary business knowledge and intellec-
tual property. In particular, offshore outsourcing is vulnerable to high turnover rates
which create potential problems relating to sharing company trade secrets with a new
employer and competitor (Hemphill 2005). Moreover, potential subcontractors in de-
veloping countries might find it more profitable by undertaking imitation instead of
subcontracting. Under these circumstances, what is the role of intellectual property
in affecting MNEs’ incentive to outsource R&D as well as local firms’ incentive to
switch from an imitator to a R&D subcontractor? How should developing countries
reform their IPR policy to be more conducive to their R&D activities in the age of
globalization of R&D?
Previous research has addressed the question of whether developing countries can
benefit from protecting intellectual property. It has been argued that strengthening
intellectual property was not in the interest of developing countries as stronger in-
tellectual property leads to an increase in the imitation cost of the Southern firms
3For example, bringing a new molecule to the market in the pharmaceutical industry was esti-
mated at about $800 million in 2005, out of which a significant portion was spent on testing the
drug on patients prior to commercial approval. A recent McKinsey study has suggested that cost
saving in the drug research process is about $200 million if clinical trials are carried out in India.
See “The HINDU survey of Indian Industry 2004” available at http://www.thehindu.com.
4
(Chin and Grossman 1990), reduction of consumer surplus due to monopoly pricing
(Deardorff 1992), diminishing in both the long-run Northern rate of innovation and
Southern welfare (Helpman 1993) .
Recently, economists began to realize that developing countries could benefit from
stronger IPR in several aspects. Maskus and Penubarti(1995), Maskus (2000), Yang
and Maskus (2001) and Chen and Puttitanun (2005) are the recent studies focusing on
how stronger IPR could encourage inward flows of technology, a faster ability to close
this gap in technological sophistication between themselves and rich countries and a
flowering of local innovation. For instance, Yang and Maskus (2001) demonstrate that
stronger IPR could increase long-run technology transfer and innovation if the mode
of transfer is licensing as stronger IPR reduces the costs of such transfers relative to
imitation costs and increases the licensor’s share of production rents.
Another strand of the literature analyzes the impacts of intellectual property
protection on R&D incentives and technology transfer in the presence of “tourna-
ment effect”. Chowdhury (2005) argues that if patent protection makes the R&D
competition into tournament, it reduces R&D investment if the tournament effect
is negative. Mukherjee (2006) shows that the effect of either imitation or technol-
ogy licensing may always dominate the tournament effect and create higher R&D
investment under patent protection.4
The above literature, however, has not touched on the impacts of stronger in-
tellectual property in developing countries on the contractual R&D activities which
have proliferated in recent years. Our paper fills this void by offering a new perspec-
tive on the protection of IPRs in developing countries and establishing a link between
4In a related paper, Mukherjee and Pennings (2004) discuss the relationship between the choice
of technology adoption and patent protection when an incumbent faces the threat of imitation from
an entrant.
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intellectual property and offshore outsourcing of R&D.
We consider a model where two firms in a developing country, one multinational
and one local, produce a product composed of two components. The multinational
firm and the local firm have competitive advantage in conducting R&D on component
1 and component 2 respectively. The multinational firm always undertakes R&D
on component 1 due to its competitive advantage. The local firm, however, can
either undertake R&D on component 2 and license it to the multinational firm as a
subcontractor or imitate the multinational firm’s technology on component 1 as an
imitator, depending on the intellectual property protection in developing countries.
In a three-stage game where the choice of the local firm as a subcontractor or imitator
is determined in the first stage and two firms engage in process R&D or imitation
in the second stage and then Cournot competition in the third stage, we find the
following results.
First, we demonstrate that strong IPR in developing countries may induce firms,
both multinational and local, to specialize in one stage of R&D, a “specialization
effect” attributed to strong IPR. Second, we consider the possibility that an original
imitator in developing countries may not be an imitator forever. Instead, it could
eventually become a potential innovator. We show that there is a “switching effect”
due to strong IPR. Third, in contrast to the conventional wisdom, our paper sug-
gests that multinational firm’s strategic behavior on IPR enforcement can be used as
an effective instrument to subsidize contractual research and development in devel-
oping countries, which is beneficial to both local firms and multinational firms (the
subsidizing effect). Fourth, we find that the welfare of developing countries could
rise with strengthened IPR under large cost saving from contractual R&D and the
relatively strong bargaining position of the Southern firm. Fifth, we illustrate how
a policy mix of IPR and FDI subsidy in developing countries affects R&D activi-
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ties adding an offshore R&D subsidiary as an additional organizational form. Our
analysis suggests that stronger patent protection is likely to expand the international
contractual R&D activities. Alternatively, developing countries with weak patent
protection could offer incentives to multinational firms in establishing offshore R&D
subsidiaries by reducing their R&D subsidiary setup costs.
Our paper is most closely related to Chen and Puttitanun (2005).5 They consider
a model of a developing country that has two sectors, an import sector and a local
sector. While stronger IPR encourage domestic innovation in the local sector, it
also makes it more difficult for a domestic imitator to imitate the more advanced
foreign firm’s technology in the import sector. Hence the choice of IPR in developing
countries needs to balance these two effects. In contrast, we focus on the role of IPR
in the context where both a MNE and a local firm have competitive advantage in
one stage of the R&D chain of a complex technology in the same sector. We also
consider the possibility that an original imitator in developing countries may not be
an imitator forever. Instead, it could eventually become a potential innovator.
The rest of our paper is organized as follows. In the next section we present a basic
model of R&D offshore outsourcing. We analyze the equilibrium outcomes under no
patent protection in section 3 and under strengthened patent protection in section
4, respectively. We then demonstrate how the equilibrium outcomes will be changed
by allowing for the multinationals firms’ strategic behavior on IPR enforcement in
section 5. The impacts of strengthened IPR on the welfare of the developing country
5Our paper is also related to the literature on outsourcing. See Grossman and Helpman (2005),
Jones (2005), Chen, et al., (2004), Riezman and Wang (2008), Mukherjee and Dinda (forthcoming),
among others. However, the above literature does not look into the international R&D outsourcing
and the impacts of intellectual property in developing countries from a North-South perspective,
which is the focus of our paper.
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are studied in section 6. We further examine how the Southern government can
choose a policy mix of IPR and FDI subsidy by adding an R&D subsidiary as an
alternative organizational form in section 7. We offer concluding remarks and some
possible extensions in the final section.
2 The basic setup
In this section we lay out a model which captures the recent trend of interna-
tionalization of R&D activities, as discussed in the introduction section. Consider a
market with two firms, one N firm (the multinational) and one S firm (the local),6
producing a homogeneous product using two components and competing in Cournot
fashion. If a represents the market size of the world, the inverse-demand function for
our product is given by P = a − q, where P is the price of the product and q the
quantity produced.7 Let ci(i = 1, 2) denote firms’ marginal production costs related
to the first and second component, respectively, before process innovation or imita-
tion.8 Firms’ marginal production costs related to component i can be reduced to c˜i
by process innovation and to αc˜i by imitation. Here α is a parameter representing
firms’ imitation capacity given by such characteristics of the South as education level
and infrastructure, where a lower value of α indicates higher imitation capacity. Since
the imitator has no access to tacit knowledge including know-how and information
6Our findings remain qualitatively intact with different numbers of Southern firms engaging in
quantity competition.
7We assume that market size a is sufficiently greater than marginal costs to ensure positive
production of both firms.
8The R&D we consider in this paper is cost-reduction R&D, or process innovation, as most
contractual R&D activities in developing countries are targeted at cost reduction instead of quality
improvement.
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gained from experience, we have α > 1. Hence we have c˜i < αc˜i < ci. Thus, both
imitation and innovation reduce firms’ marginal cost but the decline is greater in the
latter case.
Assume that the N firm has competitive advantage in conducting R&D on compo-
nent 1 because it has higher technological level; the S firm has competitive advantage
in conducting R&D on component 2 because it has the advantage of lower labor
cost and some other advantages discussed in the introduction section. To focus on
the analysis of firms’ incentive to undertake contractual R&D, we assume that only
the N firm conducts process innovation on component 1 before the game starts. We
also assume that the N firm produces in the North and the S firm produces in the
South.9 Let RN and RS denote R&D costs on component 2 of the N firm and the
S firm. Here we assume RS < RN , reflecting the competitive advantage of the S
firm in conducting R&D on component 2. Therefore the N firm can either under-
take in-house R&D on component 2 or outsource the R&D on component 2 to the
S firm.10 If offshore outsourcing of R&D occurs, we assume that the N firm offers
9In this paper we have chosen to focus on the effects of change in IPR regime on contractual
R&D activities between the North and the South. Therefore, issues including trade in final goods
and intermediate goods as well as the offshore outsourcing of production are beyond the scope of
this paper.
10In principle, the N firm could also license the technology on component 1 to the S firm to take
advantage of the low cost in the South. However, licensing of the technology on component 1 from
the N firm to the S firm is often not feasible in the real world for two reasons. First, the N firm
tends to protect its core technologies from leakage. Second, transferring the core technology would
incur high technology transfer cost due to the low learning capacity in the South. For example, in
the pharmaceutical industry it is not easy for the N firm to license the core technology because these
big N pharmaceutical firms have to conduct a lot of worldwide tests to satisfy the FDA (Federal
Drug Authority) in the USA, which are not feasible for the S firms as the amount of resources are
beyond their reach.
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a take-it-or-leave-it contract with a lump-sum license fee to the S firm which the S
firm accepts if it is not worse-off compared to that without licensing. Consequently,
the S firm gets its reservation value and all the surplus accrues to the N firm. We
denote the lump-sum license fee by L, which must be paid to acquire the technology
on component 2 innovated by the S firm.
The time sequence of the game is as follows. In the first stage, the N firm offers
the R&D contract which the S firm may accept or reject. If the contract is accepted,
the S firm undertakes R&D in component 2 and licenses it to the N firm in stage 2
and both firms compete in quantities in a Cournot setting in stage 3. If the contract
is rejected, in the second stage the N firm undertakes in-house R&D on component
2 and the S firm chooses among three strategies: (i) imitating the technology on
component 1 without undertaking R&D on component 2; (ii) conducting R&D in
component 2 without imitating the technology on component 1; (iii) imitating the
technology on component 1 along with undertaking R&D on component 2.11 Both
firms compete in quantities in a Cournot setting and profits are realized in stage 3.12
In this context we assume that f ( , ) represents the production relationship be-
tween marginal production costs of components and the firms’ marginal production
cost of the product, where the first (second) argument is the marginal cost of the
11By assuming that RS < piS(c˜1 + c˜2, c1 + c˜2)−piS(c˜1 + c˜2, c1 + c2), strategy (ii) always dominates
the strategy of no imitation or no innovation, a potential fourth strategy. This assumption is made
to minimize technical details that are not essential for our results. Our findings remain intact if we
relax this assumption.
12We rule out the possibility that the N firm can imitate the S firm’s technology on component
2 to avoid the complication of the model. One practical justification for this assumption is the S
firm not only applies for a patent for its technology in developing counties, but also in developed
countries. Hence, it makes it harder for the N firm to imitate the S firm’s technology as the patent
protection is much stronger in developed countries.
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component 1(component 2).13 Suppose the N firm’s marginal production cost of the
product are cN and c˜N in the absence and presence of process R&D on component
2, respectively. Thus, we have cN = f(c˜1, c2) and c˜N = f(c˜1, c˜2). Let the S firm’s
marginal production cost be cαS, c˜S and c˜
α
S under strategy (i), (ii) and (iii), respec-
tively. Hence, we have c˜S = f(c1, c˜2), c
α
S = f(αc˜1, c2) and c˜
α
S = f(αc˜1, c˜2). We also
denote the profit function of firm j by pij ( , ) (j = N,S), where the first (second)
argument is the marginal cost of the N firm (the S firm).
We now proceed to discuss the behavior and payoff of firms in two cases: one
with no patent protection and the other with strengthened patent protection.
3 Under no patent protection
First consider the scenario where there is no patent protection in the developing
country. Strength of patent protection of a country refers to the adequacy the laws
and regulations it has in place as well as enforcement mechanism in order to provide
transparency and certainty for investors, licensees, and customers (Maskus 2004). In
our context no patent protection means that firms do not need to pay an imitation
cost if there is an infringement of existing patents.
We begin by analyzing the case with a successful licensing. In this event the S
firm undertakes R&D on component 2 and licenses it to the N firm in stage 2. We
initially focus on the case where there is no imitation under licensing. Hence, the
payoffs of the N and the S firm under licensing are given by piN(c˜N , c˜S) − L and
piS(c˜N , c˜S) + L − RS, respectively. If the N firm’s licensing contract is rejected, the
N firm undertakes in-house R&D on component 2 and the S firm chooses among
13The precise form of f ( , ) is not crucial for our results.
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three options mentioned in section 2. Under no patent protection strategy (ii) is
always dominated by strategy (iii) because the S firm does not need to pay the
imitation cost in case of patent infringement. Thus, we focus on the comparison of
payoffs under strategy (i) and (iii). If the S firm chooses to imitate the technology on
component 1 without undertaking R&D in component 2 (strategy (i)), the payoffs of
the N firm and the S firm are given by piN(c˜N , c
α
S)−RN and piS(c˜N , cαS), respectively.
If the S firm chooses to conduct R&D on component 2 along with imitating the
technology on component 1 (strategy (iii)), the payoffs of the N firm and the S firm
are piN(c˜N , c˜
α
S)−RN and piS(c˜N , c˜αS)−RS, respectively. Licensing could only occur if
the joint profit under licensing is greater than that of strategy (i) and that of strategy
(iii).
By comparing the above payoff functions, we find that the S firm’s profit under
strategy (iii) is greater than that under strategy (i) if the S firm’s R&D cost on
component 2 is less than a threshold value K1 = piS(c˜N , c˜
α
S) − piS(c˜N , cαS), where
K1 denotes the difference of the S firm’s production profit under strategy (iii) and
strategy (i). Next, we find that the joint profit of both firms under licensing is greater
than that under strategy (i) if the S firm’s R&D cost on component 2 is less than a
threshold value K2 = RN+piN(c˜N , c˜S)+piS(c˜N , c˜S)−piN(c˜N , cαS)−piS(c˜N , cαS), where K2
denotes the difference between the joint production profit under licensing and total
joint payoffs reflecting both production profits and R&D cost under strategy (i).14 We
then summarize our results as follows: (1) the S firm would accept the contract and
undertake contractual R&D with its payoff under strategy (iii) as reservation value if
RS < K1; (2) the S firm would accept the contract and undertake contractual R&D
with its payoff under strategy (i) as reservation value if K1 < RS < K2; (3) the S
firm would deny the contract and imitate the technology on component 1 without
14For simplicity we assume that K1 < K2.
12
undertaking R&D on component 2 if RS > K2 (See Appendix A for proof).
In summary, contractual R&D only occurs when RS < K2, where the value of
K2 depends on three factors: the N firm’s R&D cost on component 2, the joint profit
under contractual R&D and the joint profit under imitation which is affected by the
S firm’s imitation capacity. This result demonstrates that in an environment where
there is no patent protection in the South contractual R&D between the N firm and
the S firm becomes more likely under low S firm’s R&D cost and high N firm’s R&D
cost on component 2. Further, the lower the S firm’s imitation capacity, the more
likely is contractual R&D.
4 Under strengthened patent protection
Now consider the case with strengthened patent protection, where the Southern
country provides adequate laws and regulations as well as enforcement. It implies
that firms have to pay an imitation cost if there is an infringement of existing patents.
We first analyze the scenario where the N firm always has the incentive for strong
IPR enforcement, in the sense that the N firm always brings a law suit against the
S firm if the S firm imitates the N firm’s process innovation on component 1. In
this event firms have to pay an imitation cost if there is an infringement of existing
patents. Let I denote the S firm’s imitation cost in the form of fines from law suits.
In this event the payoffs of the N and the S firm with a successful licensing are
given by piN(c˜N , c˜S) − L and piS(c˜N , c˜S) + L − RS, respectively.15 In the absence of
15Our results would be essentially the same if we consider the possibility that the S firm commits
not to produce after a successful licensing under strengthened IPR. Under such circumstances the
N firm is a monopoly in the market and the S firm does not produce in the third stage.
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licensing, the payoffs of the N firm and the S firm are given by piN(c˜N , c
α
S)−RN + I
and piS(c˜N , c
α
S) − I under strategy (i); piN(c˜N , c˜S) − RN and piS(c˜N , c˜S) − RS under
strategy (ii); piN(c˜N , c˜
α
S)−RN + I and piS(c˜N , c˜αS)−RS − I under strategy (iii).
By comparing the above payoff functions, we find that the joint profit of both
firms under licensing is greater than that under strategy (i) if the S firm’s R&D cost
on component 2 is less than a threshold value K ′2 = RN + piN(c˜N , c˜S) + piS(c˜N , c˜S)−
piN(c˜N , c
α
S)−piS(c˜N , cαS)+I, where K ′2 denotes the difference between the joint produc-
tion profit under licensing and total joint payoff under strategy (i). Thus, we find that
a successful licensing only occurs for RS < K
′
2 and no licensing occurs otherwise. By
comparing the equilibrium under no patent protection and that under strengthened
patent protection, it can be shown that it is more likely for the S firm to undertake
contractual R&D in component 2 under strengthened patent protection than under
no patent protection as K ′2 is greater than K2 (see Appendix B for proof).
16 Hence,
we have the following proposition.
Proposition 1: Patent protection increases firms’ incentive for specialization in
undertaking R&D when each firm has competitive advantage in research and devel-
opment in one component respectively.
The economic intuition is as follows. Under no patent protection, it could be
more profitable for firms to imitate their competitor’s technology as they do not need
16If we consider the possibility that the S firm commits not to produce after a successful licensing
under strengthened IPR, contractual R&D occurs if the S firm’s R&D cost on component 2 is less
than a threshold value K ′′2 = RN +piM (c˜N )−piN (c˜N , cαS)−piS(c˜N , cαS)+I, where piM (c˜N ) denotes the
N firm’s monopoly production profit under a successful licensing. It is easy to show K ′′2 > K
′ > K.
This implies that allowing for the S firm commits not to produce after a successful licensing actually
expands the range of parameter values under which adoption of strong IPR promotes contractual
R&D in the developing country. Hence our results will be strengthened under such circumstances.
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to pay an imitation cost in the form of fines from the law suits. Strengthened patent
protection thus reduces firms’ incentive to imitate as they face the imitation cost
and enhances the S firm’s incentive to shift from imitation to conducting cooperative
R&D. The above analysis suggests that in an environment where both the multina-
tional and the local firms have their own competitive advantage in one stage of the
R&D chain, strengthened patent protection encourages the specialization of R&D
and therefore contractual R&D activities between the North and the South.
5 Strategic IPR enforcement
In previous sections we have demonstrated that patent protection encourages
international specialization in R&D, in particular in contractual R&D activities be-
tween multinationals and local firms. We next turn to an analysis on how firms’
incentive on IPR enforcement and the equilibrium results can be changed by multi-
nationals firms’ strategic behavior on IPR enforcement.
In section 4 we analyzed the scenario where the N firm always chooses to bring
a law suit against the S firm in case of patent infringement. In this section we
discuss the possibility that the N firm may choose strategic weak IPR enforcement
even though the Southern government provides adequate laws and regulations, in the
sense that the N firm may choose not to bring a law suit against the S firm when
the S firm imitates the N firm’s technology on component 1. To include the N firm’s
strategic incentive on IPR enforcement, the time sequence of the game is modified
as follows. In the first stage, given the Southern patent scope, the N firm chooses
between strong enforcement and strategic weak enforcement under contractual R&D.
If the N firm chooses strong enforcement, the S firm does not imitate the N firm’s
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technology on component 1 under contractual R&D, knowing the N firm will bring
a lawsuit against it with patent infringement. If the N firm chooses strategic weak
enforcement, the S firm is permitted to imitate the N firm’s technology on component
1 under contractual R&D. If the contract is accepted, the S firm undertakes R&D
on component 2 and licenses it to the N firm in stage 2. The S firm imitates the N
firm’s technology on component 1 if the N firm chooses strategic weak enforcement
and does not imitate otherwise. If the contract is rejected, the N firm undertakes
in-house R&D on component 2 and the S firm chooses among the three strategies
discussed in section 2 in stage 2. Under this circumstance the N firm always chooses
strong IPR enforcement with patent infringement. Both firms compete in quantities
in a Cournot setting in stage 3.
As shown in Appendix B, with strong enforcement the contractual R&D occurs
if RS < K
′
2 and does not occur otherwise. As the N firm has the new option of
strategic weak IPR enforcement, the S firm’s outside options do not change. Hence,
the payoffs of both firms in the absence of a successful R&D contract are the same as
those in section 4. In the presence of a successful R&D contract, the payoffs of the
N and the S firm are given by piN(c˜N , c˜S) − L and piS(c˜N , c˜S) + L − RS with strong
enforcement. They become piN(c˜N , c˜
α
S)−L and piS(c˜N , c˜αS)+L−RS with strategic weak
enforcement. Accordingly, the joint profit of the N and S firm under contractual R&D
is piN(c˜N , c˜S)+piS(c˜N , c˜S)−RS with strong enforcement and piN(c˜N , c˜αS)+piS(c˜N , c˜αS)−
RS with weak enforcement. As the outside options of contractual R&D with strong
enforcement are the same as those with weak enforcement, the licensing equilibrium
becomes more likely the greater the joint profit under licensing. Thus, we focus on
the comparison of joint profit under contractual R&D with strong enforcement and
that with strategic weak enforcement.
In a Cournot duopoly model the industry profit increases as one of the firms
16
are more efficient given that these two firms are reasonably close in terms of their
initial technologies (Marjit 1990).17 More specifically, in our setting it can be inferred
that the industry profit under strategic weak IPR enforcement is greater than that
under strong enforcement if cαS <
a+4c˜N
5
.18 This result suggests that strategic IPR
weak enforcement increases the joint industry profit if the technology gap of the N
firm and the S firm undertaking the potential contractual R&D is reasonably small.
Further, the N firm is better off under strategic weak IPR enforcement than that
under strong enforcement as the S firm only gets its reservation value and all surplus
accrues to the N firm.
Let K denote piN(c˜N , c˜
α
S) + piS(c˜N , c˜
α
S)− piN(c˜N , cαS)− piS(c˜N , cαS) +RN + I, which
is the difference between the joint production profit under contractual R&D with
strategic weak IPR enforcement and total joint payoff under strategy (i). Note that
the joint production profit under contractual R&D with strategic weak IPR enforce-
ment is greater than that with strong IPR enforcement, thus it can be shown that
K is greater than K ′2. Similar to the analysis in section 4, we now have the follow-
ing equilibrium results: (1) Contractual R&D occurs for RS < K where the S firm
undertakes R&D on component 2 along with imitating the N firm’s technology on
component 1 without a lawsuit from the N firm; (2) Contractual R&D does not occur
otherwise. Comparing the equilibrium results with the option of strategic weak en-
forcement and those with strong enforcement discussed in section 4, it can be shown
that for K ′2 < RS < K contractual R&D would occur if the N firm has the option of
17Let c1 and c2 denote firm 1 and firm 2’s marginal production cost and assume c1 < c2. As is
shown in Marjit (1990), the Cournot industry profit decreases with c2 if c2 <
a+4c1
5 . The economic
intuition is that the loss in profit of firm 1 can only be compensated by an increase in profit of firm
2 when the initial market share of firm 2 is sufficiently large (technology gap between firm 1 and
firm 2 is close enough).
18The condition that cαS <
a+4c˜N
5 also guarantees c˜S <
a+4c˜N
5 .
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strategic weak IPR enforcement, but would not occur with strong IPR enforcement
(See Appendix C for proof). Hence, it is more likely for the S firm to undertake
contractual R&D on component 2 by allowing for the option of strategic weak IPR
enforcement. Hence, the following proposition is immediate.
Proposition 2: The N firm’s strategic behavior on weak enforcement of IPR
may increase the possibility of contractual R&D in developing countries.
The intuition is as follows. If the S firm imitates the technology on component 1
and the N firm chooses not to bring in a lawsuit against the S firm, the S firm produces
more efficiently while the N firm’s marginal production cost does not change, which
in turn increases the total industry profit and makes the licensing more likely. The
N firm’s payoff increases since it extracts all the increase in the industry profit as
it makes a take-it-or-leave-it contract to the S firm. Under such circumstances the
option of strategic weak IPR enforcement encourages contractual R&D activities.
We illustrate the above equilibrium results under different circumstances in Figure
1, where the horizontal axis represents the S firm’s R&D cost on component 2 and
the vertical axis represents the joint profits. Here ΠNPC , Π
SP
C and Π
WE
C are defined
as the joint profit under contractual R&D with no patent protection, strong patent
protection with strong enforcement and strong patent protection with strategic weak
enforcement, respectively. ΠNPI , Π
SP
I and Π
WE
I are defined as the joint profit under
imitation without innovation with no patent protection, strong patent protection with
strong enforcement and strong patent protection with strategic weak enforcement,
respectively. The joint profits under contractual R&D correspond to the downward
sloping lines as they decrease with the S firm’s R&D cost on component 2. The joint
profits under imitation without innovation correspond to the horizontal lines as they
are independent of the S firm’s R&D cost on component 2.
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As shown in Figure 1, in the first case where there is no patent protection, the
joint profit under contractual R&D (ΠNPC ) exceeds that under imitation without
innovation (ΠNPI ) if RS < K2 and vice versa, thus the curve of Π
NP
C is above the
curve of ΠNPI for RS < K2 and below the curve of Π
NP
I for RS > K2. Hence,
under no patent protection contractual R&D is the equilibrium if RS is less than the
threshold value K2 and imitation without innovation is the equilibrium otherwise.
With strengthened patent protection along with strong enforcement, the joint profit
under contractual R&D (ΠSPC ) does not change (Π
SP
C = Π
NP
C ) while the joint profit
under imitation without innovation (ΠSPI ) is lower due to the presence of the imitation
cost (ΠSPI < Π
NP
I ). Therefore, the two curves, Π
NP
C and Π
SP
C , coincide with each other
while the curve of ΠSPI is below the curve of Π
NP
I , accordingly the threshold value
becomes K ′2. Thus, in the case of strengthened patent protection, contractual R&D
is the equilibrium if RS is less than the threshold value K
′
2 and imitation without
innovation is the equilibrium otherwise. Finally, in the event of strategic weak IPR
enforcement, the joint profit under contractual R&D (ΠWEC ) expands due to the
increase in the S firm’s efficiency (ΠWEC > Π
SP
C ) while the joint profit under imitation
without innovation (ΠWEI ) remains unchanged (Π
WE
I = Π
SP
I ). It follows that the
curves of ΠWEI and Π
SP
I coincide with each other while the curve of Π
WE
C is above
the curve of ΠSPC , hence the threshold value changes to K.
19 That is, in the case of
strategic weak IPR enforcement, contractual R&D is the equilibrium if RS is less than
the threshold value K and imitation without innovation is the equilibrium otherwise.
In Appendix A and B, we show that K2 < K
′
2 < K.
19Note that K1 is not shown in the figure because it involves the comparison of the S firm’s profit
under strategy (i) and (iii), but not the comparison of the joint profit.
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6 Welfare impacts of IPR policy
We have discussed the role of IPR in encouraging contractual R&D activity be-
tween the N firm and the S firm. It is of interest to evaluate the impacts of changes
in the patent regime on the welfare of the Southern country, defined as the sum of
local consumer surplus and the S firm’s production profit. The detailed calculations
in this context are complex and, to save space, we simply overview the results here
(See Appendix D for mathematical computations).
6.1 Welfare impacts of strengthened IPR
We first discuss the change in Southern welfare from no patent protection to
strengthened patent protection. Here we focus on the analysis of the case where in
equilibrium the S firm is an imitator without innovation under no patent protection
and becomes an innovator undertaking contractual R&D under strengthened patent
protection. The policy shift from no patent protection to strengthened IPR in de-
veloping countries has two distinct effects on the domestic welfare. First, this policy
shift encourages contractual R&D, which increases the productivity of the S firm and
expands consumption in the Southern market. Second, the increase in imitation cost
decreases the S firm’s profit under imitation, thereby decreasing its reservation value
under licensing. Accordingly, strengthened IPR decreases the S firm’s profit under
licensing. However, the consumer gain due to the increase in the S firm’s produc-
tivity becomes larger with the increase in the cost saving shifting from imitation to
innovation. Further, as the S firm’s bargaining strength increases, the S firm’s profit
as well as the Southern welfare will be enhanced with the strengthened IPR.20 In
20The S firm’s bargaining strength will be increased as the S firm may license its technology on one
component to multiple N firms who produce differentiated goods but all use the S firm’s technology
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brief, strengthened patent protection will raise local welfare with large cost saving
from innovation and the relatively strong bargaining position of the Southern firm.
6.2 Welfare impacts of strategic IPR Enforcement
For the change in Southern welfare when shifting from strong enforcement to
strategic weak enforcement, we mainly discuss the case where the equilibrium regime
is imitation without innovation under strong enforcement and it becomes contractual
R&D under strategic weak enforcement. Upon reaching the licensing equilibrium
range, the S firm’s productivity is increased which expands consumer gains in the
Southern market. The S firm’s profit does not change under strategic weak IPR
enforcement as it gets the same reservation value as that under strong IPR enforce-
ment. Accordingly, the Southern welfare rises with the N firm’s strategic weak IPR
enforcement. However, given the choice of imitating the N firm’s process innovation
on component 1, the S firm may have less incentive to undertake R&D on component
1, thereby reducing the S firm’s bargaining strength and diminishing the Southern
welfare if we extend the evaluation to a longer time horizon.
7 Adding offshore R&D subsidiary
We have analyzed the multinational firm’s choice between undertaking in-house
R&D and outsourcing the contractual R&D to a local firm. An alternative organiza-
tional choice for a multinational firm is to establish a wholly-owned R&D subsidiary
in developing countries. Increasingly, multinational firms have established not only
sales and manufacturing operations but also research and development facilities in
as one stage in the R&D chain. We will discuss this situation in section 8.
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developing countries. By setting up R&D subsidiaries in developing countries, multi-
national firms are able to take advantage of lower R&D cost in developing countries.
To capture this feature, we now incorporate a simple specification of an R&D sub-
sidiary into the model.
Suppose the N firm has the option of establishing an R&D subsidiary in the South.
Following Antra`s and Helpman (2004), we assume that the fixed organizational cost
under integration abroad (set up an R&D subsidiary) is greater than that under
outsourcing (conducting contractual R&D activities with local firms). To simplify
the analysis, we assume that a setup cost f is incurred under integration (set up an
R&D subsidiary) while no setup cost is incurred under outsourcing. We also assume
that the R&D cost on component 2 of the S subsidiary is RS, the same as that of the
S firm undertaking contractual R&D, reflecting the fact that the S subsidiary is also
able to take advantage of lower R&D cost in developing countries. As a result, the
cost difference between conducting R&D through an R&D subsidiary and through
outsourcing is the setup cost f .21
In this setup, the N firm has two outside options: conducting in-house R&D
in the North and setting up an R&D subsidiary in the South, while the S firm
has three outside options set out in previous sections in case of a breakup of the
negotiation of contractual R&D. Working through the payoff functions we have the
following results.22 If the subsidiary setup costs are large and patent protection is
weak, in equilibrium the N firm conducts in-house R&D. In this event the N firm
does not choose an R&D subsidiary due to the large setup cost, while the S firm
has no incentive to undertake contractual R&D due to the high reservation value
under imitation. As the Southern countries strengthens its patent protection, the
21In this section we focus on the case without strategic weak IPR enforcement.
22See Appendix E for proof.
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equilibrium shifts from integration at home (conducting in-house R&D in the North)
to outsourcing (undertaking contractual R&D), where the Southern firm shifts from
an imitator to an innovator undertaking contractual R&D. If subsidiary setup costs
are sufficiently small while patent protection is weak, in equilibrium the N firm chooses
to conduct R&D via an R&D subsidiary. Strengthened patent protection shifts the
equilibrium from integration abroad (setting up an R&D subsidiary) to outsourcing
(undertaking contractual R&D) in this event.
The above results can be characterized as follows. In developing countries where
subsidiary setup costs are large and patent protection is weak, the N firm chooses
to conduct in-house R&D in the North. Strengthened patent protection encourages
contractual R&D as it increases the S firm’s incentive to change from an imitator
to an innovator. Alternatively, the Southern country with weak patent protection
may be able to attract an R&D subsidiary by reducing the setup costs of the R&D
subsidiary. In particular, the Southern government could focus on the improvement
of infrastructure, the institutions as well as providing multinational firms with FDI
subsidies including job-creation subsidies, tax cut and even the construction of indus-
trial facilities. Strengthened patent protection could further encourage contractual
R&D activities between the N firm and the S firm.
8 Concluding remarks
This paper offers a new perspective on the protection of intellectual property in
developing countries. We develop a model to illustrate the important role of intellec-
tual property in shaping the landscape of international specialization in research and
development. Our analysis yields several interesting results. First, by reducing the
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Southern firm’s profits under imitation, strengthened intellectual property protection
in developing countries increases the Southern firm’s incentive to undertake contrac-
tual R&D, thereby encouraging the international specialization in R&D. Second, the
multinational firm’s strategic behavior on weak enforcement of IPR may encourage
contractual R&D in developing countries. This is due to the increase in the total
industry profit extracted by the multinational firm as the S firm produces more effi-
ciently under strategic weak IPR enforcement. Further, we find that Southern welfare
could rise with strengthened IPR under large cost saving from innovation and the
relatively strong bargaining position of the Southern firm. Finally, we show how a
policy mix of IPR and FDI subsidy in developing countries affects R&D activities by
adding an offshore R&D subsidiary as an alternative organizational form.
Given the recent surge in international fragmentation in both production and
research and development, the policy implications we find here may be helpful for
policymakers in developing countries in fashioning their reforms in intellectual prop-
erty. Specifically, our analysis suggests that stronger patent protection is likely to
expand the international contractual R&D activities where both a multinational firm
and a local firm have competitive advantage in one stage of the R&D chain respec-
tively. Alternatively, the Southern country with weak patent protection could offer
incentives to multinational firms in establishing offshore R&D subsidiaries by reduc-
ing their R&D subsidiary setup costs.
Our analysis can be extended to more general environments. We have assumed
that the S firm can only license its technology on one component of a product to
one N firm. However, in the real world it is possible that the S firm may license its
technology on one component to multiple N firms who produce differentiated goods
but all use the S firm’s technology as one stage in the R&D chain. For example, a
lot of pharmaceutical firms in India are licensing the technology on one molecule to
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multiple multinational firms who use molecule as one component of their product.
If we include this possibility in our model, the S firm’s bargaining power will be
increased in the sense that there are a large number of potential buyers. It is likely
that the N firms only get their reservation values and all the surplus accrues to the S
firm. Hence, the S firm has more incentive to change from an imitator to an innovator
who undertakes contractual R&D and our conclusions will be strengthened.
Another promising avenue for future research is to extend the analysis to examine
the impact of a policy mix of R&D subsidy policy and IPR policy on R&D offshore
outsourcing. The R&D subsidy policy in developing countries can be affected by
their IPR policy as strengthened IPR policy may change domestic firms’ incentive to
undertake contractual R&D. This analysis will be important for developing countries
as R&D subsidy policy plays a vital role in shaping domestic innovative capacity
which are considered to be central to domestic economic growth.
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Appendix A: Equilibrium results under no patent protection.
This appendix provides a detailed illustration of the equilibrium results in the
presence of licensing under no patent protection.
The Generalized Nash Bargaining Solution is
piN = dN + τ(pi − dN − dS) and piS = dS + (1 − τ)(pi − dN − dS). Here, piN
and piS are the Nash bargaining solutions; pi is the joint profit of both firms under
licensing; τ is the bargaining power of player N, and 1− τ is the bargaining power of
player S; dN and dS are the disagreement points.
In this paper we assume that the N firm offers a take-it-or-leave-it contract to
the S firm in this paper, thus the N firm’s bargaining power τ is equal to 1. And the
payoffs of the N and S firm under a successful licensing are
piN = dN + (pi − dN − dS) and piS = dS.
Hence, a successful licensing only occurs when the joint profit of both firms under
licensing is greater than that under an outside option.
The joint profit under licensing is given by piN(c˜N , c˜S) + piS(c˜N , c˜S) − RS. And
the joint profit under strategy (i), (ii) and (iii) is given by
piN(c˜N , c
α
S)+piS(c˜N , c
α
S)−RN , piN(c˜N , c˜S)+piS(c˜N , c˜S)−RN−RS, and piN(c˜N , c˜αS)+
piS(c˜N , c˜
α
S)−RN −RS, respectively.
It is obvious that the joint profit under strategy (ii) is always less than that under
licensing.
For simplicity, we assume that the N firm’s R&D cost on component 2 is so high
that RN > piN(c˜N , c˜
α
S) + piS(c˜N , c˜
α
S)− piN(c˜N , c˜S)− piS(c˜N , c˜S), which implies that the
joint profit under licensing is greater than that under strategy (iii).
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The S firm’s payoffs under strategy (i), (ii) and (iii) under no patent protection
are piS(c˜N , c
α
S), piS(c˜N , c˜S)−RS and piS(c˜N , c˜αS)−RS, respectively. It is straightforward
that its payoff under strategy (ii) is always dominated by strategy (iii) because the S
firm does not need to pay the imitation cost in case of patent infringement under no
patent protection. Thus, we focus on the analysis on payoffs of strategy (i) and (iii).
Let K1 denote piS(c˜N , c˜
α
S)−piS(c˜N , cαS). Then strategy (iii) dominates strategy (i)
for the S firm if RS < K1. Let K2 denote RN +piN(c˜N , c˜S)+piS(c˜N , c˜S)−piN(c˜N , cαS)−
piS(c˜N , c
α
S). Thus, the joint profit under licensing is greater than that under strategy
(i) if RS < K2. For simplicity we assume K1 < K2.
Therefore, we have the following findings:
If RS > K1, strategy (i) dominates strategy (iii) for the S firm. A successful
licensing where the reservation values are the payoffs under strategy (i) occurs if
K1 < RS < K2 and will not occur if RS > K2.
If RS < K1, strategy (iii) dominates strategy (i) for the S firm. In this case a
successful licensing where the reservation values are payoffs under strategy (iii) always
occurs.
In short, a successful licensing occurs where the reservation values are payoffs
under strategy (iii) for RS < K1; a successful licensing occurs where the reservation
values are the payoffs under strategy (i) for K1 < RS < K2 and no licensing occurs
for RS > K2. The corresponding licensing fee is L = piS(c˜N , c˜
α
S) − piS(c˜N , c˜S) for
RS < K1 and L = RS + piS(c˜N , c
α
S)− piS(c˜N , c˜S) for K1 < RS < K2.
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Appendix B: Proof of Proposition 1.
With strengthened patent protection, the joint profit under licensing is given by
piN(c˜N , c˜S) + piS(c˜N , c˜S) − RS. And the joint profit under strategy (i), (ii) and (iii)
is given by piN(c˜N , c
α
S) + piS(c˜N , c
α
S) − RN , piN(c˜N , c˜S) + piS(c˜N , c˜S) − RN − RS, and
piN(c˜N , c˜
α
S) + piS(c˜N , c˜
α
S)−RN −RS, respectively.
The S firm’s payoff under strategy (i), (ii) and (iii) in the absence of a successful
licensing under strengthened patent protection are piS(c˜N , c
α
S) − I, piS(c˜N , c˜S) − RS
and piS(c˜N , c˜
α
S)−RS − I, respectively. Here we discuss two cases.
I. If I < piS(c˜N , c˜
α
S) − piS(c˜N , c˜S), strategy (iii) dominates strategy (ii) and the
analysis is similar to that in Appendix A. LetK ′2 denote RN+piN(c˜N , c˜S)+piS(c˜N , c˜S)−
piN(c˜N , c
α
S)− piS(c˜N , cαS) + I. We then have the following findings:
If RS > K1, strategy (i) dominates strategy (iii) for the S firm. The S firm
chooses strategy (i) in stage 2. A successful licensing where the reservation values are
the payoffs under strategy (i) occurs if K1 < RS < K
′
2 and will not occur if RS > K
′
2.
If RS < K1, strategy (iii) dominates strategy (i) for the S firm. In this case a
successful licensing where the reservation values are payoffs under strategy (iii) always
occurs.
In summary, a successful licensing occurs where the reservation values are payoffs
under strategy (iii) for RS < K1; a successful licensing where the reservation values
are the payoffs under strategy (i) occurs for K1 < RS < K
′
2 and no licensing occurs
for RS > K
′
2 when I < piS(c˜N , c˜
α
S)− piS(c˜N , c˜S). Therefore, a successful licensing only
occurs for RS < K
′
2, which shows that strengthened patent protection increases firms’
incentive for specialization in undertaking R&D as K ′2 is greater than K2.
II. If I > piS(c˜N , c˜
α
S) − piS(c˜N , c˜S), strategy (ii) dominates strategy (iii). Let K3
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denote I + piS(c˜N , c˜S)− piS(c˜N , cαS). Thus, we have the following findings:
If RS < K3, strategy (ii) dominates strategy (i). Since the joint profit under
strategy (ii) is always greater than that under licensing, a successful licensing always
occurs where the reservation values are payoffs under strategy (ii).
If RS > K3, strategy (i) dominates strategy (ii). The S firm chooses strategy (i)
in stage 2. A successful licensing occurs where the reservation values are the payoffs
under strategy (i) if K3 < RS < K
′
2 and will not occur if RS > K
′
2.
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In summary, a successful licensing occurs where the reservation values are payoffs
under strategy (ii) for RS < K3; a successful licensing where the reservation values
are the payoffs under strategy (i) occurs for K3 < RS < K
′
2 and no licensing occurs
for RS > K
′
2 when I > piS(c˜N , c˜
α
S) − piS(c˜N , c˜S). Again, it shows that strengthened
patent protection increases firms’ incentive for specialization in undertaking R&D as
K ′2 is greater than K2.
Appendix C: Proof of Proposition 2.
This appendix proves Proposition 2.
As shown in Appendix B, with strong enforcement the contractual licensing oc-
curs if RS > K
′
2 and does not occur otherwise. As the N firm has the new option of
strategic weak IPR enforcement, the S firm’s outside options do not change. Accord-
ingly both firms’ reservation values without licensing have no change, but the joint
profit under licensing will be changed due to the N firm’ new option of strategic weak
IPR enforcement. The joint profit of the N and S firm under contractual R&D is
23Here we assume that K ′2 > K3. The conclusion will not be changed if we relax this assumption.
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piN(c˜N , c˜S)+piS(c˜N , c˜S)−RS with strong enforcement and piN(c˜N , c˜αS)+piS(c˜N , c˜αS)−RS
with weak enforcement. We show that the joint industry profit with weak enforce-
ment is greater than that with strong enforcement in the text, therefore the N firm
opts for strategic weak enforcement under contractual R&D.
Let K denote piN(c˜N , c˜
α
S) + piS(c˜N , c˜
α
S)− piN(c˜N , cαS)− piS(c˜N , cαS) +RN + I. Then
the joint profit under contractual R&D with weak enforcement is greater than that
under outside options for RS < K. In short, we have the following equilibrium
results: (1) Contractual R&D occurs for RS < K where the S firm undertakes R&D
on component 2 along with imitating the N firm’s technology on component 1 without
a lawsuit from the N firm; (2) Contractual R&D does not occur otherwise.
Comparing K ′2 with K, it is straightforward to show that K is greater than K
′
2.
Hence, we find that for K ′2 < RS < K contractual R&D would occur if the N firm
has the option of strategic weak IPR enforcement, but would not occur with strong
IPR enforcement.
Appendix D: Southern welfare
D.1 Southern welfare with no patent protection
Welfare of the Southern country is the sum of local consumer surplus and the S
firm’s production profit. Let qN and qS denote output of the N and S firm in the
Southern country. Then the Southern welfare is given by WS = 0.5(qS + qN)
2 + piS.
For RS < K1 a successful licensing occurs where the reservation values are payoffs
under strategy (iii), hence the southern welfare is given by WS =
(2a−c˜N−c˜S)2
18
+
(a+c˜N−2c˜αS)2
9
−RS.
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For K1 < RS < K2 a successful licensing occurs where the reservation values are
the payoffs under strategy (i), hence the southern welfare is given by
WS =
(2a− c˜N − c˜S)2
18
+
(a+ c˜N − 2cαS)2
9
.
For RS > K2, no licensing occurs and strategy (i) is the equilibrium. The South-
ern welfare is given by WS =
(2a−c˜N−cαS)2
18
+
(a+c˜N−2cαS)2
9
.
D.2 Southern welfare with strengthened patent protection
Under strengthened patent protection, we mainly discuss the case when I <
piS(c˜N , c˜
α
S) − piS(c˜N , c˜S), which implies that strategy (iii) dominates strategy (ii) for
the S firm.
For RS < K1, a successful licensing occurs where the reservation values are payoffs
under strategy (iii). The Southern welfare is given by
WS =
(2a− c˜N − c˜S)2
18
+
(a+ c˜N − 2c˜αS)2
9
−RS − I.
For K1 < RS < K
′
2, a successful licensing occurs where the reservation values are
the payoffs under strategy (i). The Southern welfare is given by WS =
(2a−c˜N−c˜S)2
18
+
(a+c˜N−2cαS)2
9
− I.
For KS > K
′
2, no licensing occurs while strategy (i) is the equilibrium. The
Southern welfare is given by WS =
(2a−c˜N−cαS)2
18
+
(a+c˜N−2cαS)2
9
− I
D.3 Change in southern welfare shifting from no patent protection to
strengthened patent protection
Here we focus on the analysis of the case where in equilibrium the S firm is an
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imitator under no patent protection and becomes an innovator undertaking contrac-
tual R&D under strengthened patent protection for K2 < RS < K
′
2. Under no patent
protection, the Southern welfare is WS =
(2a−c˜N−cαS)2
18
+
(a+c˜N−2cαS)2
9
− I.
Under strengthened patent protection, it becomes
WS =
(2a− c˜N − c˜S)2
18
+
(a+ c˜N − 2cαS)2
9
− I.
D.4 Southern welfare with strategic weak enforcement
With the strategic weak enforcement, a successful licensing occurs where the
reservation values are payoffs under strategy (iii) for RS < K1. There the Southern
welfare is
WS =
(2a− c˜N − c˜αS)2
18
+
(a+ c˜N − 2c˜αS)2
9
−RS
For K1 < RS < K, a successful licensing occurs where the reservation values are
the payoffs under strategy (i). Hence, the Southern welfare is WS =
(2a−c˜N−c˜αS)2
18
+
(a+c˜N−2cαS)2
9
− I.
For RS > K
′
2, no licensing occurs while strategy (i) is the equilibrium. Hence,
the Southern welfare is WS =
(2a−c˜N−cαS)2
18
+
(a+c˜N−2cαS)2
9
− I.
D.5 Change in southern welfare shifting from strong enforcement to
strategic weak enforcement
Here we mainly discuss the case where the equilibrium regime is imitation without
innovation under strong enforcement and it becomes contractual R&D under strategic
weak enforcement for K ′2 < RS < K.
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Under strong enforcement, the Southern welfare is given by WS =
(2a−c˜N−cαS)2
18
+
(a+c˜N−2cαS)2
9
− I.
Under strategic weak enforcement it becomes WS =
(2a−c˜N−c˜αS)2
18
+
(a+c˜N−2cαS)2
9
− I.
Appendix E: Equilibrium results with a R&D subsidiary
First consider the case that the setting up cost of a R&D subsidiary is sufficiently
large (f > RN − RS). In this event the N firm’s profit of conducting in-house R&D
in the North is greater than that via a R&D subsidiary. As a result the equilibrium
results are the same as those illustrated in Appendix B. Under weak patent protection
the N firm conducts in-house R&D. As the Southern countries strengthened patent
protection, the equilibrium shifts from integration at home (conducting in-house R&D
in the North) to outsourcing (undertaking contractual R&D), where the Southern firm
shifts from an imitator to an innovator.
Next consider the case that the setting up cost of a R&D subsidiary is sufficiently
small (f < RN −RS). In this case the N firm’s profit of conducting in-house R&D in
the North is less than that via a R&D subsidiary. Under the circumstance that the S
firm’s payoff under option (i) has the highest value among the three outside options,
the joint surplus of both firms is given by +piN(c˜N , c˜S) + piS(c˜N , c˜S) − piN(c˜N , cαS) −
piS(c˜N , c
α
S). As a result, contractual R&D would occur if f > piN(c˜N , c
α
S)+piS(c˜N , c
α
S)−
piN(c˜N , c˜S)−piS(c˜N , c˜S). Thus, under weak patent protection (smallI), in equilibrium
contractual R&D does not occur and the N firm chooses to conduct R&D via an
R&D subsidiary. Strengthened patent protection (largeI) shifts the equilibrium from
integration abroad (set up an R&D subsidiary) to outsourcing (undertake contractual
R&D). If the S firm’s payoff under option (ii) has the highest value among the three
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outside options, the joint surplus of both firms is given by RS + f . In this case
contractual R&D always happens and larger setting up cost increases the N firm’s
incentive of cooperating with the S firm. Under the circumstance that the S firm’s
payoff under option (iii) has the highest value among the three outside options, the
joint surplus of both firms is given by RS +f +piN(c˜N , c˜S)+piS(c˜N , c˜S)−piN(c˜N , c˜αS)−
piS(c˜N , c˜
α
S). Accordingly, contractual R&D would occur if RS + f > piN(c˜N , c˜
α
S) +
piS(c˜N , c˜
α
S)−piN(c˜N , c˜S)−piS(c˜N , c˜S). In this case the analysis is similar to that where
the S firm’s payoff under option (i) has the highest value among the three outside
options.
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Figure 1. Equilibrium Results under Different Circumstances
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